Patients with Squamous cell cancer neck nodes
Showing 1 - 25 of >10,000
Hypopharyngeal Carcinoma Trial in China (drug, radiation, procedure)
Not yet recruiting
- Hypopharyngeal Carcinoma
- Docetaxel
- +4 more
-
Beijing, Beijing, China
- +3 more
Aug 9, 2022
Cervical/Supraclavicular Metastasis From Non-small-cell Lung
Recruiting
- Lung Cancer Metastatic
- Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
- Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023
Head and Neck Squamous Cell Carcinoma Trial in Palo Alto (Panitumumab-IRDye800, Lymphoseek)
Suspended
- Head and Neck Squamous Cell Carcinoma
-
Palo Alto, CaliforniaStanford University, School of Medicine
Aug 16, 2021
Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Panitumumab
- +9 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jun 4, 2023
Head and Neck Squamous-cell Carcinoma
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- +2 more
- (no location specified)
Nov 5, 2023
Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)
Recruiting
- Squamous Cell Carcinoma
- Head and Neck Cancer
- Intensity-modulated radiotherapy
- Magnetic Resonance Guidance
-
Tampa, FloridaMoffitt Cancer Center
Nov 13, 2023
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy
Not yet recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Toripalimab
- Stereotactic Body Radiation Therapy (SBRT)
-
Tianjin, China
- +1 more
May 16, 2023
Squamous Cell Carcinoma of the Oropharynx Trial in United States (Radiation Therapy)
Not yet recruiting
- Squamous Cell Carcinoma of the Oropharynx
- Radiation Therapy
-
Miami, Florida
- +3 more
Jul 22, 2023
Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Pirfenidone
- Placebo
-
Guangzhou, Guangdong, China
- +4 more
Nov 16, 2023
Head and Neck Squamous Cell Carcinoma, Oral Cancer Trial in Guangzhou (Tirelizumab ,+Carboplatin+albumin-bound paclitaxel)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Oral Cancer
- Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
-
Guangzhou, Guangdong, ChinaSun yat-sun memorial hospital
Jul 10, 2023
Oral Cancer, PD-1 Trial in Guangzhou (PD-1 with chemo, upright surgery)
Recruiting
- Oral Cancer
- PD-1
- PD-1 with chemotherapy
- upright surgery
-
Guangzhou, Guangdong, ChinaSun yat-sen memorial hospital
Nov 12, 2023
Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)
Not yet recruiting
- Oral Squamous Cell Carcinoma
- Neck Dissection
- Elective neck dissection
- Therapeutic neck dissection
- (no location specified)
Apr 10, 2023
Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- PET/CT
- Neck dissection
- (no location specified)
Jan 31, 2023
Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint
Not yet recruiting
- Recurrent Head and Neck Cancer
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 30, 2023
Squamous Cell Carcinoma of the Head and Neck Trial in Portland (Intratumoral Ipilimumab)
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Intratumoral Ipilimumab
-
Portland, OregonPortland Providence Medical Center
Jan 8, 2023
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Pembrolizumab
- +3 more
-
Boston, Massachusetts
- +1 more
Feb 11, 2023
Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node
Recruiting
- Squamous Cell Carcinoma
- +2 more
- sentinel lymph node biopsy (SLNB)
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 15, 2022
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Active, not recruiting
- Cutaneous Squamous Cell Carcinoma
- +10 more
- Regular care with additional administration of a semi-structured interview
-
Maastricht, NetherlandsMaastricht University Medical Center+
Sep 13, 2023
Sentinel Lymph Node, Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (peritumoral microbubbles and contrast-enhanced
Recruiting
- Sentinel Lymph Node
- Head and Neck Squamous Cell Carcinoma
- peritumoral microbubbles and contrast-enhanced ultrasonography
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Jun 26, 2022
Vulvar Cancer Trial (ICG alone)
Not yet recruiting
- Vulvar Cancer
- ICG alone
- (no location specified)
Sep 8, 2023
Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Panitumumab-IRDye800
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jul 13, 2023
Head and Neck Squamous Cell Carcinoma Trial in Dallas (Intensity modulated radiation therapy (IMRT))
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Intensity modulated radiation therapy (IMRT)
-
Dallas, TexasUniversity of Texas Southwestern Medical Center - Dallas
Nov 18, 2022
Cancer of Unknown Primary Site, Unknown Primary Cancer, Unknown Primary, Squamous Cell Carcinoma Trial in Copenhagen, Ã…rhus
Recruiting
- Cancer of Unknown Primary Site
- +2 more
- Transoral Ultrasound
-
Copenhagen, Denmark
- +1 more
May 2, 2023
Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Locally Advanced Operable
- Cadonilimab
- +2 more
-
Guangzhou, Guangdong, China
- +1 more
Sep 4, 2023
Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)
Not yet recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab + Dasatinib + Quercetin
- surgery
- (no location specified)
Feb 2, 2023